BlackRock Institutional Trust’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$8.08M Buy
489,439
+66,161
+16% +$1.12M ﹤0.01% 2522
2016
Q3
$7.75M Buy
423,278
+101,354
+31% +$1.78M ﹤0.01% 2491
2016
Q2
$5.16M Buy
321,924
+93,420
+41% +$1.09M ﹤0.01% 2668
2016
Q1
$2.19M Sell
228,504
-954
-0.4% -$13.5K ﹤0.01% 3003
2015
Q4
$4.12M Buy
229,458
+674
+0.3% +$12.4K ﹤0.01% 2814
2015
Q3
$5.1M Buy
+228,784
New +$6.18M ﹤0.01% 2707

Other funds holding TDOC

BlackRock Institutional Trust's TDOC Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Teladoc Health (TDOC) stake by 16% in Q4 2016, buying an estimated $1.12M and bringing the position to 489,439 shares worth $8.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2522.

BlackRock Institutional Trust first reported a position in TDOC in Q3 2015 and has held it in 6 quarters since. 108 funds tracked by Wall St. Rank hold TDOC as of Q4 2016.

  • BlackRock Institutional Trust held 489,439 shares of Teladoc Health worth $8.08M as of Q4 2016.
  • BlackRock Institutional Trust bought 66,161 Teladoc Health shares in Q4 2016, an estimated $1.12M.
  • Teladoc Health made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2522 holding.
  • BlackRock Institutional Trust first reported a position in Teladoc Health in Q3 2015 and has held it in 6 quarters since.
  • 108 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.